ALOPECIA AREATA(AA)
Clinical trials for ALOPECIA AREATA(AA) explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA(AA) trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA(AA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug VIS171 enters human trials for lupus, hair loss, and kidney disease
Disease control OngoingThis early-stage trial tests a new drug called VIS171 in 30 people with lupus, alopecia areata, or a kidney condition called FSGS. The main goal is to check safety and how the body handles the drug. Participants receive VIS171 as a shot under the skin, alongside their usual care,…
Matched conditions: ALOPECIA AREATA(AA)
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a simple blood test help understand hair loss?
Knowledge-focused ENROLLING_BY_INVITATIONThis observational study examines whether certain blood markers (VEGF-A and VCAM-1) are linked to nailfold capillary changes in people with alopecia areata. Researchers will compare 90 participants (patients with acute or chronic alopecia areata and healthy volunteers) using bloo…
Matched conditions: ALOPECIA AREATA(AA)
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC